Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

245 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Automatic analysis of skull thickness, scalp-to-cortex distance and association with age and sex in cognitively normal elderly.
Zhang J, Treyer V, Sun J, Zhang C, Gietl A, Hock C, Razansky D, Nitsch RM, Ni R; Alzheimer's Disease Neuroimaging Initiative. Zhang J, et al. Among authors: nitsch rm. Brain Stimul. 2023 Mar-Apr;16(2):653-656. doi: 10.1016/j.brs.2023.03.011. Epub 2023 Mar 22. Brain Stimul. 2023. PMID: 36963563 Free article. No abstract available.
Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid.
Garcia-Pavia P, Aus dem Siepen F, Donal E, Lairez O, van der Meer P, Kristen AV, Mercuri MF, Michalon A, Frost RJA, Grimm J, Nitsch RM, Hock C, Kahr PC, Damy T. Garcia-Pavia P, et al. Among authors: nitsch rm. N Engl J Med. 2023 Jul 20;389(3):239-250. doi: 10.1056/NEJMoa2303765. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212440 Clinical Trial.
Age-, sex-, and pathology-related variability in brain structure and cognition.
Bachmann D, Buchmann A, Studer S, Saake A, Rauen K, Zuber I, Gruber E, Nitsch RM, Hock C, Gietl A, Treyer V. Bachmann D, et al. Among authors: nitsch rm. Transl Psychiatry. 2023 Aug 14;13(1):278. doi: 10.1038/s41398-023-02572-6. Transl Psychiatry. 2023. PMID: 37574523 Free PMC article.
Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab.
Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P. Chen T, et al. Among authors: nitsch rm. Alzheimers Dement. 2024 Apr 3. doi: 10.1002/alz.13755. Online ahead of print. Alzheimers Dement. 2024. PMID: 38567735
245 results